Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2026)

Precision Biosciences (DTIL) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $299000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 24.3% year-over-year to $299000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 43.73% YoY), while the FY2025 annual figure was $1.5 million, down 56.87% from the prior year.
• Depreciation & Amortization (CF) declined to $299000.0 in Q1 2026 per DTIL's latest filing, from $345000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $2.0 million in Q1 2022 and bottomed at $299000.0 in Q1 2026.
• Historically, Depreciation & Amortization (CF) has averaged $1.1 million across 5 years, with a median of $842000.0 in 2024.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) plunged 66.82% — and 2024, when it jumped 31.56%.
• Precision Biosciences' Depreciation & Amortization (CF) stood at $2.0 million in 2022, then tumbled by 34.74% to $1.3 million in 2023, then slumped by 64.5% to $454000.0 in 2024, then decreased by 24.01% to $345000.0 in 2025, then declined by 13.33% to $299000.0 in 2026.
• Business Quant data shows DTIL's Depreciation & Amortization (CF) at $299000.0 in Q1 2026, $345000.0 in Q4 2025, and $309000.0 in Q3 2025.